secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHEMED CORP (CHE)
CIK:        0000019584
Form:       8-K
Filed at:   2026-04-23T23:59:59+00:00
Accession:  0000019584-26-000010
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemed Q1 adjusted EPS $5.65; boosts 2026 guidance to $24.00-$24.75 on VITAS momentum
--------------------------------------------------------------------------------

- GAAP diluted EPS $4.84, down 0.4% YoY; adjusted EPS $5.65, up 0.4% YoY.
- Revenue $657.5M (+1.6%); VITAS revenue $420.0M (+3.1%); Roto-Rooter revenue $237.5M (-0.9%).
- VITAS ADC up 2.2% to 22,723; admissions up 6.9%; adjusted EBITDA ex-Medicare Cap $70.8M (+0.6%), margin 16.8%.
- Roto-Rooter adjusted EBITDA $53.5M (-9.6%), margin 22.5% (-218bps); acquired two franchises for $20.6M.
- FY 2026 adjusted EPS guidance raised to $24.00-$24.75 from $23.25-$24.25; repurchased 500k shares for $197.7M in Q1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/19584/000001958426000010/0000019584-26-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/19584/000001958426000010/che-20260423x8k.htm
  HTML page:      https://secwatch.observer/filing/0000019584-26-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer